News Headlines Article

Company hikes price 5,000% for drug that fights complication of AIDS, cancer
USA Today

A drug treating a common parasite that attacks people with weakened immune systems increased in cost 5,000% to $750 per pill.

At a time of heightened attention to the rising cost of prescription drugs, doctors who treat patients with AIDS and cancer are denouncing the new cost to treat a condition that can be life-threatening.

Turing Pharmaceuticals of New York raised the price of Daraprim from $13.50 per pill to $750 per pill last month, shortly after purchasing the rights to the drug from Impax Laboratories. Turing has exclusive rights to market Daraprim (pyrimethamine), on the market since 1953.

Commands